Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

1.21
Delayed Data
As of Aug 28
 +0.15 / +14.15%
Today’s Change
0.84
Today|||52-Week Range
8.23
-52.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues854.0K896.0K854.0K854.0K
 
 
 
 
 
Depreciation And Amortization7.0K11.0K11.0K11.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses14.2M12.0M9.6M11.5M
 
 
 
 
 
Research And Development6.9M6.0M4.5M6.3M
 
 
 
 
 
Total Operating Expenses14.2M12.1M9.6M11.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.3M-11.2M-8.8M-10.6M
 
 
 
 
 
Extraordinary Charge-1.6M---89.0K-1.7M
 
 
 
 
Interest Expense On Debt391.0K311.0K239.0K233.0K
 
 
 
 
 
Other Expenses11.0K10.1M-31.0K3.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.3M-1.3M-9.1M-8.9M
 
 
 
 
 
Net Income-15.3M-1.3M-9.1M-8.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.5M63.0M67.6M72.5M
 
 
 
 
 
Shares To Calculate EPS Diluted60.5M63.0M67.6M72.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.02-$0.13-$0.15
 
 
 
 
 
EPS Diluted-$0.25-$0.02-$0.13-$0.15